Usman Siddiqui, MD
Clinical Cardiac Electrophysiology · Winter Park, FLNPI 1467623199
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 50 manufacturers reported payments, led by Abbott at 34.6% of the total. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,276 payments — averaging $542.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$427K
- Medtronic$351K
- Acutus Medical, Inc.$134K
- Anumana, Inc.$54K
- Medical Device Business Services, Inc.$34K
- Impulse Dynamics (USA) Inc.$33K
- plus $201K from 44 others
Across 441 payments — averaging $5269.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$1.3M
- Medtronic$771K
- Amgen$118K
- Impulse Dynamics (USA) Inc.$65K
- Boston Scientific$26K
- Cvrx, Inc.$21K
- plus $24K from 2 others
Across 1 payment — averaging $24,864 each. An ownership or investment interest held by the physician or an immediate family member.
- Anumana, Inc.$25K
What the payments were for
- Consulting fees$558,13945%
- Speaking & faculty fees$406,34933%
- Travel & lodging$202,77216%
- Food & beverage$66,4125%
- Education$2150%
- Entertainment$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$190,450
- Ensite Cardiac Mapping System$88,376
- ECG-AI LEF$48,000
- OPTIMIZER$39,834
- Micra$35,679
- Carto 3$27,946
- AFFERA MAPPING SYSTEM$26,913
- PulseSelect$23,466
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$20,961
- CAMZYOS$18,407
- FIRMAP$15,445
- Accent Pacemaker$14,896
- VADO$13,423
- OPTIMIZER SMART SYSTEM$11,862
- ViewMate Intracardiac Echo$11,216
- NAGARE$9,572
- LifeVest$8,575
- AVEIR$8,378
- CellFX$7,641
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$7,570
How this compares
$1,233,914 in reported general payments places this provider in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 298 | $303,350 |
| EntrestoSacubitril/Valsartan | 97 | $137,851 |
| XareltoRivaroxaban | 95 | $100,079 |
| FarxigaDapagliflozin Propanediol | 29 | $34,241 |
| JardianceEmpagliflozin | 15 | $19,664 |
| Dofetilide | 58 | $14,003 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 27 | $10,489 |
| Metoprolol Succinate | 270 | $3,966 |
| SotalolSotalol Hcl | 172 | $3,889 |
| Amiodarone Hcl | 72 | $1,573 |
| Flecainide Acetate | 50 | $1,228 |
| Metoprolol Tartrate | 145 | $1,098 |
| Carvedilol | 98 | $844 |
| ClopidogrelClopidogrel Bisulfate | 78 | $833 |
| Sucralfate | 91 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $303,350298 claims |
| NovartisEntresto | $7,462 | $137,85197 claims |
| Johnson & JohnsonXarelto | $189 | $100,07995 claims |
| AstraZenecaFarxiga | $161 | $34,24129 claims |
| Boehringer IngelheimJardiance | $133 | $19,66415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Winter Park
- Glenn DymWinter Park$86K
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.